NasdaqGS - Nasdaq Real Time Price USD
10x Genomics, Inc. (TXG)
9.53
+0.19
+(2.09%)
At close: May 30 at 4:00:00 PM EDT
9.55
+0.02
+(0.21%)
After hours: May 30 at 7:19:55 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.08 | -0.01 | -0.08 | -0.03 |
| Low Estimate | -0.1 | -0.06 | -0.18 | -0.11 |
| High Estimate | -0.06 | 0.04 | 0.02 | 0.06 |
| Year Ago EPS | 0 | -0.02 | -0.35 | -0.08 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 16 | 16 |
| Avg. Estimate | 139.38M | 143.55M | 590.37M | 624M |
| Low Estimate | 137.79M | 139M | 571.59M | 581.37M |
| High Estimate | 140.9M | 147.5M | 610M | 670M |
| Year Ago Sales | 153.1M | 151.65M | 610.78M | 590.37M |
| Sales Growth (year/est) | -8.97% | -5.35% | -3.34% | 5.70% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.26 | -0.11 | -0.29 |
| EPS Actual | 0 | -0.02 | -0.14 | -0.1 |
| Difference | 0.24 | 0.24 | -0.03 | 0.19 |
| Surprise % | 102.17% | 94.13% | -27.12% | 64.90% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.08 | -0.01 | -0.08 | -0.03 |
| 7 Days Ago | -0.14 | -0.08 | -0.54 | -0.42 |
| 30 Days Ago | -0.14 | -0.08 | -0.54 | -0.42 |
| 60 Days Ago | -0.14 | -0.08 | -0.54 | -0.42 |
| 90 Days Ago | -0.13 | -0.04 | -0.6 | -0.05 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | 2 | 2 |
| Up Last 30 Days | 2 | 2 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TXG | -1,700.00% | 34.51% | 76.99% | 68.75% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 5/19/2025 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 5/15/2025 |
| Maintains | UBS: Neutral to Neutral | 5/13/2025 |
| Maintains | Goldman Sachs: Sell to Sell | 5/12/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 5/12/2025 |
| Maintains | JP Morgan: Neutral to Neutral | 5/9/2025 |
Related Tickers
TDOC Teladoc Health, Inc.
6.92
-0.86%
SDGR Schrödinger, Inc.
21.62
+0.84%
CERT Certara, Inc.
11.36
-0.35%
PHR Phreesia, Inc.
24.49
+0.25%
DOCS Doximity, Inc.
52.09
+0.29%
EVH Evolent Health, Inc.
7.45
+1.09%
WEAV Weave Communications, Inc.
9.65
+0.84%
HQY HealthEquity, Inc.
100.61
-0.37%
WAY Waystar Holding Corp.
39.98
+3.68%
OMCL Omnicell, Inc.
30.37
+1.81%